Contribution: Industrial Research Assistance Program – Contributions to Firms
Rehabtronics Inc.
$523,600.00
ITEA: 22022 TREAT - Transforming Healthcare Through Semantic Interoperability & Patient Self-Efficacy
FY 2023-24 · 2024-01-01
Summary
This is an IRAP International project (EUREKA Clusters ITEA,TREAT, ID# 22022) for a consortium led by My Viva Inc. (Canadian).
As part of the international consortium project, Rehabtronics will further develop the Prelivia product line. Prelivia is a first-in-class intervention for pressure injuries (PIs), which are a deadly medical complication. This project supports Prelivia's product strategy through the development and implementation of Internet of Medical Things connectivity, AI-driven patient monitoring and digital health ecosystem interoperability. The outcomes of this project will lead to new revenue generating products and features, retain and create highly qualified personnel, commercialize solutions for a massive healthcare problem, and save thousands of lives.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Edmonton|Edmonton, Alberta, Canada
Recipient Type
For-profit organization
Business Number
867910408
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2024-01-01 | 2023-24 | $380,600.00 |
| 1 | 2024-01-01 | 2023-24 | $523,600.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The total amended value is 143,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 143 000 dollars.
Agreement End Date
2026-12-31
Agreement Number
1015901
Agreement Start Date
2024-01-01
Agreement Title
ITEA: 22022 TREAT - Transforming Healthcare Through Semantic Interoperability & Patient Self-Efficacy
Agreement Title (French)
ITEA : 22022 TREAT— Transformer les soins de santé grâce à l’interopérabilité sémantique et à l’auto-efficacité des patients
Agreement Type
Contribution
Agreement Value
$523,600.00
Amendment Date
2025-03-20
Amendment Number
1
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This is an IRAP International project (EUREKA Clusters ITEA,TREAT, ID# 22022) for a consortium led by My Viva Inc. (Canadian).
As part of the international consortium project, Rehabtronics will further develop the Prelivia product line. Prelivia is a first-in-class intervention for pressure injuries (PIs), which are a deadly medical complication. This project supports Prelivia's product strategy through the development and implementation of Internet of Medical Things connectivity, AI-driven patient monitoring and digital health ecosystem interoperability. The outcomes of this project will lead to new revenue generating products and features, retain and create highly qualified personnel, commercialize solutions for a massive healthcare problem, and save thousands of lives.
Description (French)
Il s’agit d’un projet international du PARI (EUREKA grappes ITEA,TREAT, ID# 22022) pour un consortium piloté par My Viva Inc. (canadien). Dans le cadre de ce projet de consortium international, Rehabtronics poursuivra le développement de la gamme de produits Prelivia. Prelivia est la première intervention de sa catégorie pour les lésions dues à la pression, qui sont une complication médicale mortelle. Ce projet soutient la stratégie produit de Prelivia grâce au développement et à la mise en œuvre de la connectivité de l’Internet des objets médicaux, de la surveillance des patients pilotée par l’IA et de l’interopérabilité de l’écosystème de la santé numérique. Les résultats de ce projet conduiront à de nouveaux produits et fonctionnalités générateurs de revenus, à retenir et créer du personnel hautement qualifié, à commercialiser des solutions pour un problème massif de soins de santé et à sauver des milliers de vies.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Centre
Federal Riding (French)
Edmonton-Centre
Federal Riding Number
48014
NAICS Code
339110
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
867910408
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
Rehabtronics Inc.
Recipient Operating Name
Rehabtronics
Recipient Postal Code
T5J 4P6
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2023-2024-Q4-1015901
